Positron Emission Tomography/Computed Tomography in Bladder Carcinoma
PDF
Cite
Share
Request
Review
P: 13-17
March 2015

Positron Emission Tomography/Computed Tomography in Bladder Carcinoma

Bull Urooncol 2015;14(1):13-17
1. Dokuz Eylül Üniversitesi Tip Fakültesi, Nükleer Tip Anabilim Dali, Izmir, Türkiye
2. Dokuz Eylül Üniversitesi Tip Fakültesi, Üroloji Anabilim Dali, Izmir, Türkiye
No information available.
No information available
Received Date: 30.11.2014
Accepted Date: 30.12.2014
PDF
Cite
Share
Request

ABSTRACT

The purpose of the current review was to conduct a systemic review and meta-analysis of the published literature to discuss the role of positron emission tomography (PET) or positron emission tomography-computed tomography (PET/CT) in urinary bladder cancer. PET/CT has a limited role in the detection of urinary system cancers because fluorodeoxyglucose (FDG) is e xcreted with urine. However removal of F-18 FDG from the bladder with diuretic and oral hydration has a role in the detection and restaging of bladder cancer with PET/CT. Locoregional lymph node metastasis is an important prognostic factor in patients with bladder cancer. The ability to identify metastatic disease preoperatively is of utmost importance in determining treatment. Multimodal treatment, depending on preoperative stage, may improve survival.

Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House